Please ensure Javascript is enabled for purposes of website accessibility Cir.No. 53 of 2026 - Regarding Update to Health Care Professionals About Nasal decongestant sprays and drops containing xylometazoline hydrochloride / oxymetazoline hydrochloride: increased risk of rebound congestion, rhinitis medicamentosa, and tachyphy Cir.No. 53 of 2026 - Regarding Update to Health Care Professionals About Nasal decongestant sprays and drops containing xylometazoline hydrochloride / oxymetazoline hydrochloride: increased risk of rebound congestion, rhinitis medicamentosa, and tachyphy

Cir.No. 53 of 2026 - Regarding Update to Health Care Professionals About Nasal decongestant sprays and drops containing xylometazoline hydrochloride / oxymetazoline hydrochloride: increased risk of rebound congestion, rhinitis medicamentosa, and tachyphy

التفاصيل
دائرة التيقظ والمعلومات الدوائية الأخبار وتنبيهات السلامة
Cir.No. 53 of 2026 - Regarding Update to Health Care Professionals About Nasal decongestant sprays and drops containing xylometazoline hydrochloride / oxymetazoline hydrochloride: increased risk of rebound congestion, rhinitis medicamentosa, and tachyphy
14‏/05‏/2026

Cir.No. 53 of 2026 - Regarding Update to Health Care Professionals About Nasal decongestant sprays and drops containing xylometazoline hydrochloride / oxymetazoline hydrochloride: increased risk of rebound congestion, rhinitis medicamentosa, and tachyphy

0
Cir.No. 53 of 2026 - Regarding Update to Health Care Professionals About Nasal decongestant sprays and drops containing xylometazoline hydrochloride / oxymetazoline hydrochloride: increased risk of rebound congestion, rhinitis medicamentosa, and tachyphy
هل استفدت من المعلومات المقدمة في هذه الصفحة؟
0 من الزوار أعجبهم محتوى الصفحة من أصل 0 مشاركة
كن اول من يقيم محتوى هذه الصفحة

اضف السبب (اختر من خيار واحد إلى خياران)

الرجاء اختيار سببان كحد أعلى

هذا الحقل مطلوب

الرجاء كتابة نص صحيح

الملاحظات يجب ان تكون اقل من ٢٥٠ حرف

//
آخر تحديث: منذ يومين (2026‏/05‏/16)
تابعونا على